ROIVANT SCIENCES
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
ROIVANT SCIENCES
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Product Research
Founded:
2014-05-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.roivant.com
Total Employee:
501+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.09 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Nginx Amazon
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-26 | Silicon Therapeutics | Silicon Therapeutics acquired by Roivant Sciences | 450 M USD |
Investors List
Eventide
Eventide investment in Post-IPO Equity - Roivant Sciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Post-IPO Equity - Roivant Sciences
Viking Global Investors
Viking Global Investors investment in Post-IPO Equity - Roivant Sciences
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - Roivant Sciences
Patient Square Capital
Patient Square Capital investment in Post-IPO Equity - Roivant Sciences
Palantir Technologies
Palantir Technologies investment in Post-IPO Equity - Roivant Sciences
Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma investment in Post-IPO Equity - Roivant Sciences
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Roivant Sciences
SoftBank Capital
SoftBank Capital investment in Post-IPO Equity - Roivant Sciences
Novaquest Capital Management
Novaquest Capital Management investment in Private Equity Round - Roivant Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-03 | Medallion | Roivant Sciences investment in Series B - Medallion | 30 M USD |
| 2021-11-01 | gen-t | Roivant Sciences investment in Pre Seed Round - gen-t | 2 M USD |
| 2021-08-02 | Immunovant | Roivant Sciences investment in Post-IPO Equity - Immunovant | 200 M USD |
| 2020-10-08 | Datavant | Roivant Sciences investment in Series B - Datavant | 40 M USD |
| 2018-04-30 | Datavant | Roivant Sciences investment in Venture Round - Datavant | 40.5 M USD |
| 2017-10-02 | Arbutus Biopharma | Roivant Sciences investment in Post-IPO Equity - Arbutus Biopharma | 116.4 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-02 | Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation |
Official Site Inspections
http://www.roivant.com Semrush global rank: 836.93 K Semrush visits lastest month: 45.72 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
